The Global Fund matters. Last week in a New York Times Op-ed piece Paul Farmer -- chairman of the department of global health and social medicine at Harvard Medical School and a co-founder of Partners in Health -- made a compelling case for the critical importance of the Fund. Citing dramatic improvements in the global health landscape since the Fund’s inception, he argues convincingly that lives will be lost if it falters. Since the Global Fund began, malaria deaths in most African nations are down 40 percent, and more than three million people in sub-Saharan Africa are on antiretrovirals (ARVs), both in large part due to the resources mobilized by the Fund.
And the impact goes beyond AIDS, tuberculosis and malaria. By working with health ministries and supporting healthcare professionals, the Global Fund has helped improve health systems and infrastructure in countries receiving grants, leading to better overall health outcomes in developing countries. The Fund’s unique partnership model draws on and ensures multistakeholder engagement at the country-level, from the board down to implementing partners. Business, government, communities of people living with the three diseases, health experts and public health practitioners are all at the table.
GBCHealth and its coalition members stand with the Global Fund. As the Focal Point for the Private Sector Delegation (PSD) on the Board of the Fund, GBCHealth works with dozens of committed businesses willing to contribute to the Global Fund's agenda, advise the board's deliberations, ensure that the body remains performance-driven and advocate for the business role in global health.